Study of VXCO-100, a SARS-CoV Candidate Vaccine in Healthy Adults in the United States
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Angela Branche, MD
University of Rochester
Principal Investigator - Justin Ortiz, MD, MS
University of Maryland
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Hope Clinic of Emory University
Decatur, Georgia, United States
- University of Maryland, Baltimore, Center for Vaccine Development and Global Health
Baltimore, Maryland, United States
- University of Rochester Medical Center - Vaccine Research Unit
Rochester, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 May 2023
- Primary completion
- 10 Apr 2024
- Completion
- 10 Apr 2024
- Last update posted
- 10 Dec 2024
- Registered enrollment
- 121
- Registry id
- NCT05870839
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.